From: Adverse event reporting in randomised trials of neuropathic pain: challenges for clinical usefulness of safety data
Criteria
n (%)
Most frequent AEs
17 (32)
All AE’s that occurred
Other
6 (11)
A pre-specified list of AEs
5 (9.4)
Unclear
3 (5.7)
Not applicable as no AE reported
Any AE with sig diff between treatment groups
2 (3.8)